Section 32 focus areas include biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence. The firm’s goal is to improve the human condition by accelerating the discovery, development, adoption and distribution of important technologies and life saving medicines. Bill Maris, Founder Mike Pellini MD, Managing Partner Steve Kafka PhD, Managing Partner Andy Harrison, Managing Partner Lindsey Acharya, Chief of Staff Vivian Chao, Controller Alice Cheung, Head of Talent Vanessie Christensen, Operations Evalynne Dacayanan, Operations Kenzo Fong Hing, Advisor Susan Hager, Chief Investor Relations & Chief Communications Officer Nina Labatt, Chief Financial Officer & Chief Operating Officer Sarah Larson, Chief People Officer Brittany Schnaars, Operations Kimberly Shih, Talent Specialist Carlos Solórzano, Senior Principal Wesley Tillu, Senior Principal Ainhoa ("Noa") Maiz, Senior Principal Tom Zhang, Head of Data Follow us on Twitter: https://twitter.com/section32vc